Skip to main content
. 2010 Jul 7;84(19):10169–10181. doi: 10.1128/JVI.00568-10

TABLE 1.

Pathology development in HI-infected/667 MAb-treated and LI-infected/nontreated mice

Mouse group Wk 3
Wk 30
Survival Survival % Hematocrita Spleen massb (g)
HI infected/667 MAb treated 30/30c 30/30c 50 ± 1 0.08 ± 0.04
LI infected/nontreated 30/30c 0/30c 36 ± 2.3 1.65 ± 0.3
a

Percent hematocrit was measured as described in Materials and Methods.

b

Spleens were weighed after sacrifice.

c

Number of mice in each group.